<ARTICLE> 5 <CIK> 0000898437 <NAME> ANIKA THERAPEUTICS, INC. <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-31-1999 <PERIOD-START> JAN-01-1999 <PERIOD-END> JUN-30-1999 <CASH> 5,218,037 <SECURITIES> 10,158,240 <RECEIVABLES> 2,897,423 <ALLOWANCES> (57,000) <INVENTORY> 4,018,018 <CURRENT-ASSETS> 22,845,220 <PP&E> 7,157,431 <DEPRECIATION> (4,160,340) <TOTAL-ASSETS> 31,835,692 <CURRENT-LIABILITIES> 2,434,868 <BONDS> 0 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 99,919 <OTHER-SE> 29,278,198 <TOTAL-LIABILITY-AND-EQUITY> 31,835,692 <SALES> 6,974,853 <TOTAL-REVENUES> 6,974,853 <CGS> 3,604,804 <TOTAL-COSTS> 3,604,804 <OTHER-EXPENSES> 3,194,847 <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 0 <INCOME-PRETAX> 775,231 <INCOME-TAX> 23,584 <INCOME-CONTINUING> 751,647 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 751,647 <EPS-BASIC> .08 <EPS-DILUTED> .07